Minapharm Pharmaceuticals Q3 Consol Profit EGP 16.8 Million

About this update from Minapharm Pharmaceuticals

MINAPHARM PHARMACEUTICALS SAE EGX:MIPH:MINAPHARM PHARMACEUTICALS Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 16.8 MILLIONMINAPHARM PHARMACEUTICALS Q3 CONSOL REVENUE EGP 1.50 BILLION

View stock analysis, news, and events for Minapharm Pharmaceuticals